AiMedic Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series A
- Investors
-
10
AiMedic General Information
Description
Developer of diagnostic tools designed to treat coronary diseases. The company offers artificial intelligence and simulation-based tools with medical image analysis, automated segmentation, physiological modeling, and functional assessment tools to assist in the diagnosis and treatment planning of cardiovascular conditions, enabling healthcare providers such as clinicians and radiologists to evaluate cardiac conditions accurately and support informed clinical decisions.
Contact Information
Website
www.aimedic.krCorporate Office
- 7th Floor, 326 Dosan-daero, Nonhyeon-dong
- Gangnam-gu
- Seoul, 06097
- South Korea
Corporate Office
- 7th Floor, 326 Dosan-daero, Nonhyeon-dong
- Gangnam-gu
- Seoul, 06097
- South Korea
AiMedic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 11-Oct-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 29-Feb-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 30-Apr-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Oct-2016 | $449K | Completed | Generating Revenue | ||
| 1. Seed Round | 31-Aug-2016 | $449K | $449K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AiMedic Patents
AiMedic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11145224-B2 | Blood flow simulation method and apparatus for subject-specific blood vessel | Active | 15-Oct-2019 | ||
| US-20210256877-A1 | Blood flow simulation method and apparatus for subject-specific blood vessel | Active | 15-Oct-2019 | ||
| EP-3836146-A1 | Method and apparatus for simulating blood flow of subject-specific blood vessel | Active | 15-Oct-2019 | ||
| EP-3836146-A4 | Method and apparatus for simulating blood flow of subject-specific blood vessel | Active | 15-Oct-2019 | ||
| EP-3836146-B1 | Method and apparatus for simulating blood flow of subject-specific blood vessel | Active | 15-Oct-2019 | G16H50/50 |
AiMedic Signals
AiMedic Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Entels | Corporation | Minority | ||
| KB Investment | Venture Capital | Minority | ||
| Lifecore Partners | Venture Capital | Minority | ||
| S Ventures (Korea) | Venture Capital | Minority | ||
| InterValue Partners | Venture Capital | Minority |
AiMedic FAQs
-
When was AiMedic founded?
AiMedic was founded in 2014.
-
Where is AiMedic headquartered?
AiMedic is headquartered in Seoul, South Korea.
-
What is the size of AiMedic?
AiMedic has 29 total employees.
-
What industry is AiMedic in?
AiMedic’s primary industry is Diagnostic Equipment.
-
Is AiMedic a private or public company?
AiMedic is a Private company.
-
What is AiMedic’s current revenue?
The current revenue for AiMedic is .
-
How much funding has AiMedic raised over time?
AiMedic has raised $10.8M.
-
Who are AiMedic’s investors?
Entels, KB Investment, Lifecore Partners, S Ventures (Korea), and InterValue Partners are 5 of 10 investors who have invested in AiMedic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process